WHO: Pandemic flu vaccine production to fall short

Sep 18, 2009
In this photo made on Friday, Sept. 11, 2009, Safety and security specialist for the Bayer Corporation U.S. headquarters, Thomas Barclay, right, receives an inoculation for influenza from company physicians assistant Tim Grimes, in the Pittsburgh suburb Robinson, Pa. The initial doses of the new swine flu vaccine will only be given to young people, pregnant women and other high-risk groups. Businesses will have to wait until those folks have been immunized to get swine flu vaccine for their workforce. Unless they jump through lots of hoops that vary from state by state to get it, creating confusion for companies, like Bayer, with offices all over the country. (AP Photo/Keith Srakocic)

(AP) -- Global production of swine flu vaccines will be "substantially less" than the previous maximum forecast of 94 million doses a week, the World Health Organization said Friday.

The number of doses produced in a year will therefore fall short of the 4.9 billion doses the global health body previously hoped could be available for the pandemic, WHO spokesman Gregory Hartl told reporters in Geneva.

Production will be lower because some manufacturers are still turning out vaccines for seasonal flu - an illness that can be serious in sick and elderly people, Hartl said.

Production problems also have reduced the weekly output of pandemic vaccine, he said.

The , France, Britain and six other countries announced Thursday that they will share part of their vaccine supply with poorer countries.

WHO welcomed the move Friday, saying it "demonstrates the commitment of these countries to fairness in sharing of scare resources."

"Current supplies of pandemic vaccine are inadequate for a world population in which virtually everyone is susceptible to infection by a new and readily contagious virus," it said.

WHO says that in theory all the world's 6.3 billion people should receive at least one dose of against the strain of H1N1 - also known as swine flu - to ensure comprehensive protection against the disease, which has so far killed some 3,500 people.

©2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Explore further: Flu vaccine may hold key to preventing heart disease

add to favorites email to friend print save as pdf

Related Stories

GlaxoSmithKline taking pandemic vaccine orders

May 15, 2009

(AP) -- Pharmaceutical giant GlaxoSmithKline said Friday it has received orders from several countries to stockpile pandemic vaccine as soon as it gets the vaccine's key ingredient from the World Health Organization.

WHO meets on production of swine flu vaccine

May 14, 2009

(AP) -- As swine flu cases hit 6,500 worldwide, World Health Organization officials were meeting with vaccine manufacturers and other experts in Geneva on Thursday to discuss making a vaccine to fight the virus.

Glaxo offers WHO 50 million pandemic vaccines

May 19, 2009

(AP) -- Drug giant GlaxoSmithKline said it has offered to donate 50 million doses of a pandemic vaccine to the World Health Organization in the event of a global flu outbreak, according to a company spokesman.

WHO: No swine flu vaccine available for months (Update)

May 19, 2009

(AP) -- Drug manufacturers won't be able to start making a swine flu vaccine until mid-July at the earliest, weeks later than previous predictions, the World Health Organization said Tuesday. It will then ...

WHO predicts 'explosion' of swine flu cases

Aug 21, 2009

(AP) -- The global spread of swine flu will endanger more lives as it speeds up in coming months and governments must boost preparations for a swift response, the World Health Organization said Friday.

Recommended for you

Supercomputers link proteins to drug side effects

Oct 20, 2014

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

No added benefit proven for umeclidinium/vilanterol in COPD

Oct 20, 2014

The drug combination umeclidinium/vilanterol (trade name Anoro) has been approved since May 2014 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform ...

User comments : 0